.Basilea Pharmaceutica's work building new antifungals has actually gotten a substantial increase fr...
.Having actually gathered up the united state rights to Capricor Therapies' late-stage Duchenne musc...
.After pushing the decision meeting for Applied Rehabs' metabolic condition drug govorestat, the FDA...
.Novo Nordisk is proceeding its push right into hereditary medicines, agreeing to pay NanoVation The...
.Innovent Biologics has created the case that its gate inhibitor-cytokine combination healthy protei...
.A stage 3 test of Daiichi Sankyo and also Merck & Co.'s HER3-directed antibody-drug conjugate (A...
.5 months after Rakovina Therapeutics pivoted toward expert system, the cancer-focused biotech has j...
.Ascendis Pharma has actually emerged as a prospective hazard to BioMarin's Voxzogo, mentioning phas...
.Though Alkeus Pharmaceuticals' oral eye illness resource neglected to substantially lower geographi...
.With a trio of biotechs attacking the Nasdaq on Friday, it was easy to miss out on a smaller-scale ...
.Immune system checkpoint preventions are the superheroes of cancer cells treatment. Medicines like ...
.Accept to today's Chutes & Ladders, our summary of substantial management hirings, shootings and...
.Regeneron is actually back along with lasting follow-up for its own LAG-3 prevention and PD-1 preve...
.AstraZeneca has actually shared a very early take a look at the functionality of its internal antib...
.After introducing a period 3 launch based on beneficial midstage results, iTeos and GSK are actuall...
.The FDA needs to be even more available and also collaborative to discharge a rise in approvals of ...
.It's an extraordinarily hectic Friday for biotech IPOs, along with Zenas BioPharma, MBX and Bicara ...
.Atea Pharmaceuticals' antiviral has stopped working an additional COVID-19 test, yet the biotech st...
.Neurocrine Biosciences' mental illness course pivot has actually fallen short. The biotech was inca...
.Sanofi has actually made an overdue entrance to the radioligand celebration, paying one hundred tho...